MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 133 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $270,000 | -16.1% | 217,900 | +108.1% | 0.00% | – |
| Q1 2017 | $322,000 | -57.9% | 104,700 | -44.1% | 0.00% | -100.0% |
| Q4 2016 | $765,000 | -35.7% | 187,400 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,190,000 | +17.8% | 187,400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,010,000 | -28.3% | 187,400 | +11.3% | 0.00% | 0.0% |
| Q1 2016 | $1,409,000 | +5.9% | 168,300 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,330,000 | -8.8% | 168,300 | -1.8% | 0.00% | 0.0% |
| Q3 2015 | $1,458,000 | -31.3% | 171,300 | -0.2% | 0.00% | -50.0% |
| Q2 2015 | $2,122,000 | +10.9% | 171,600 | +6.5% | 0.00% | 0.0% |
| Q1 2015 | $1,914,000 | +5.2% | 161,100 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,820,000 | +28.7% | 161,100 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $1,414,000 | +20.4% | 161,100 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,174,000 | +47.7% | 161,100 | +2.1% | 0.00% | 0.0% |
| Q1 2014 | $795,000 | +37.8% | 157,836 | +46.1% | 0.00% | 0.0% |
| Q4 2013 | $577,000 | -6.2% | 108,036 | -33.2% | 0.00% | 0.0% |
| Q3 2013 | $615,000 | -40.9% | 161,736 | +4.6% | 0.00% | 0.0% |
| Q2 2013 | $1,041,000 | – | 154,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|